Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: An ancillary study of the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)

Eitemau Tebyg

• Even “WISE-R?”—an Update on the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation
  gan: Barsky, Lili, et al.
  Cyhoeddwyd: (2020)
• Safety of Coronary Reactivity Testing in Women with No Obstructive Coronary Artery Disease: Results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study
  gan: Wei, Janet, et al.
  Cyhoeddwyd: (2012)
• Timing of Hormone Therapy, Type of Menopause, and Coronary Disease in Women: Data from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
  gan: Shufelt, Chrisandra, et al.
  Cyhoeddwyd: (2011)
• Association of Aortic Stiffness and Wave Reflections with Coronary Flow Reserve in Women without Obstructive Coronary Artery Disease: An Ancillary Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
  gan: Nichols, Wilmer W., et al.
  Cyhoeddwyd: (2015)
• Comparison of low and high dose intracoronary adenosine and acetylcholine in women undergoing coronary reactivity testing: results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
  gan: Petersen, John W., et al.
  Cyhoeddwyd: (2014)